Abstract：As the research progresses on intestinal flora, more and more evidences show that the imbalance of intestinal flora is closely related to the occurrence and progression of many chronic diseases. Probiotic treatment has become a worldwide hotspot, and Akkermansia muciniphlia (A. muciniphila), a common colonizer in the mucous layer of human intestines, has gradually been regarded as a promising candidate for the next-generation probiotics. The present paper summarizes the ameliorating effects of A. muciniphila on chronic diseases and the possible mechanisms, providing a new idea for the treatment of diseases.
秦珍珍，栗凤霞. 二代益生菌嗜黏蛋白阿克曼菌与慢性疾病的研究进展[J]. 微生物与感染, 2022, 17(3): 178-183.
QIN Zhenzhen, LI Fengxia. Progress on the relationship between a next-generation probiotic-Akkermansia muciniphlia and chronic disease. JOURNAL OF MICROBES AND INFECTIONS, 2022, 17(3): 178-183.